David A Sidloff1, Philip W Stather2, Edward Choke2, Matthew J Bown3, Robert D Sayers2. 1. Vascular Surgery Group, Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom. Electronic address: ds343@le.ac.uk. 2. Vascular Surgery Group, Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom. 3. Vascular Surgery Group, Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom; NIHR Leicester Biomedical Research Unit, University of Leicester, Leicester, United Kingdom.
Abstract
OBJECTIVE: The purpose of this study was to summarize the current evidence of the association between markers of hemostasis and both the presence and size of abdominal aortic aneurysms (AAAs). METHODS: A systematic review and meta-analysis was performed according to Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines by use of the search terms "aneurysm AND abdominal AND aortic AND coagulation" NOT "thoracic." Outcome data including concentration of hemostatic marker, number of patients, and significance level were recorded. RESULTS: A total of 22 nonrandomized studies were included in the analysis, with a total of 9862 patients. Fibrinogen mean difference (MD) (0.43 g/L; 95% confidence interval [CI], 0.28-0.58 g/L; P ≤ .00001), D-dimer MD (325.82 ng/mL; 95% CI, 199.74-451.89 ng/mL; P ≤ .00001), and thrombin-antithrombin III complex MD (5.58 g/L; 95% CI, 3.34-7.83 g/L; P ≤ .0001) were significantly elevated in the presence of AAAs. Tissue plasminogen activator, prothrombin fragments F1+F2, and platelet count were not shown to be significantly different between patients with and those without AAAs. Meta-regression of studies reporting plasma D-dimer concentration and aneurysm diameter suggests a strong and significant association (r(2) = 0.94; P ≤ .0001). CONCLUSIONS: This study suggests that the presence of AAAs is associated with increased fibrin turnover, fibrinolysis, and thrombin generation, as shown by increased levels of fibrinogen, D-dimer, and thrombin-antithrombin III complex. This is clinically relevant because markers of hemostasis are independent risk factors for cardiovascular events, highlighting the necessity of addressing all modifiable cardiovascular risk factors in patients with AAAs. Furthermore, the finding that plasma D-dimer concentration appears to have a linear relationship with aneurysm diameter may be useful as a future biomarker of AAAs.
OBJECTIVE: The purpose of this study was to summarize the current evidence of the association between markers of hemostasis and both the presence and size of abdominal aortic aneurysms (AAAs). METHODS: A systematic review and meta-analysis was performed according to Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines by use of the search terms "aneurysm AND abdominal AND aortic AND coagulation" NOT "thoracic." Outcome data including concentration of hemostatic marker, number of patients, and significance level were recorded. RESULTS: A total of 22 nonrandomized studies were included in the analysis, with a total of 9862 patients. Fibrinogen mean difference (MD) (0.43 g/L; 95% confidence interval [CI], 0.28-0.58 g/L; P ≤ .00001), D-dimer MD (325.82 ng/mL; 95% CI, 199.74-451.89 ng/mL; P ≤ .00001), and thrombin-antithrombin III complex MD (5.58 g/L; 95% CI, 3.34-7.83 g/L; P ≤ .0001) were significantly elevated in the presence of AAAs. Tissue plasminogen activator, prothrombin fragments F1+F2, and platelet count were not shown to be significantly different between patients with and those without AAAs. Meta-regression of studies reporting plasma D-dimer concentration and aneurysm diameter suggests a strong and significant association (r(2) = 0.94; P ≤ .0001). CONCLUSIONS: This study suggests that the presence of AAAs is associated with increased fibrin turnover, fibrinolysis, and thrombin generation, as shown by increased levels of fibrinogen, D-dimer, and thrombin-antithrombin III complex. This is clinically relevant because markers of hemostasis are independent risk factors for cardiovascular events, highlighting the necessity of addressing all modifiable cardiovascular risk factors in patients with AAAs. Furthermore, the finding that plasma D-dimer concentration appears to have a linear relationship with aneurysm diameter may be useful as a future biomarker of AAAs.
Authors: René M Botnar; Julia Brangsch; Carolin Reimann; Christian H P Janssen; Reza Razavi; Bernd Hamm; Marcus R Makowski Journal: J Am Heart Assoc Date: 2018-05-30 Impact factor: 5.501
Authors: A Phillip Owens; Todd L Edwards; Silvio Antoniak; Julia E Geddings; Eiman Jahangir; Wei-Qi Wei; Joshua C Denny; Yacine Boulaftali; Wolfgang Bergmeier; Alan Daugherty; Uchechukwu K A Sampson; Nigel Mackman Journal: Arterioscler Thromb Vasc Biol Date: 2015-07-02 Impact factor: 8.311
Authors: Alexandra C Sundermann; Keith Saum; Kelsey A Conrad; Hannah M Russell; Todd L Edwards; Kevin Mani; Martin Björck; Anders Wanhainen; A Phillip Owens Journal: Blood Adv Date: 2018-11-27
Authors: Sebastian Fernandez-Alonso; Esther Martinez-Aguilar; Susana Ravassa; Josune Orbe; Jose A Paramo; Leopoldo Fernandez-Alonso; Carmen Roncal Journal: Life (Basel) Date: 2022-05-31
Authors: Raphael R Bruno; Norbert Donner-Banzhoff; Wolfgang Söllner; Thomas Frieling; Christian Müller; Michael Christ Journal: Dtsch Arztebl Int Date: 2015-11-06 Impact factor: 5.594
Authors: Katharina T I Kornhuber; Heide Seidel; Claudia Pujol; Christian Meierhofer; Franz Röschenthaler; Axel Pressler; Alexander Stöckl; Nicole Nagdyman; Rhoia C Neidenbach; Philipp von Hundelshausen; Martin Halle; Stefan Holdenrieder; Peter Ewert; Harald Kaemmerer; Michael Hauser Journal: Cardiovasc Diagn Ther Date: 2019-10